BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8033210)

  • 1. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.
    Warren AJ; Colledge WH; Carlton MB; Evans MJ; Smith AJ; Rabbitts TH
    Cell; 1994 Jul; 78(1):45-57. PubMed ID: 8033210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of murine embryonic erythropoiesis: a spatial analysis.
    Silver L; Palis J
    Blood; 1997 Feb; 89(4):1154-64. PubMed ID: 9028937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
    Valge-Archer VE; Osada H; Warren AJ; Forster A; Li J; Baer R; Rabbitts TH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8617-21. PubMed ID: 8078932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1.
    Osada H; Grutz G; Axelson H; Forster A; Rabbitts TH
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9585-9. PubMed ID: 7568177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell oncogene rhombotin-2 interacts with retinoblastoma-binding protein 2.
    Mao S; Neale GA; Goorha RM
    Oncogene; 1997 Apr; 14(13):1531-9. PubMed ID: 9129143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
    Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knock-in mutation of transcription factor GATA-3 into the GATA-1 locus: partial rescue of GATA-1 loss of function in erythroid cells.
    Tsai FY; Browne CP; Orkin SH
    Dev Biol; 1998 Apr; 196(2):218-27. PubMed ID: 9576834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primitive erythropoiesis in the Xenopus embryo: the synergistic role of LMO-2, SCL and GATA-binding proteins.
    Mead PE; Deconinck AE; Huber TL; Orkin SH; Zon LI
    Development; 2001 Jun; 128(12):2301-8. PubMed ID: 11493549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of LMO2 mRNA and protein expression in erythroid differentiation.
    Brandt SJ; Koury MJ
    Haematologica; 2009 Apr; 94(4):447-8. PubMed ID: 19336746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
    Shivdasani RA; Mayer EL; Orkin SH
    Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells.
    Weiss MJ; Keller G; Orkin SH
    Genes Dev; 1994 May; 8(10):1184-97. PubMed ID: 7926723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice.
    Larson RC; Lavenir I; Larson TA; Baer R; Warren AJ; Wadman I; Nottage K; Rabbitts TH
    EMBO J; 1996 Mar; 15(5):1021-7. PubMed ID: 8605871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
    Yamada Y; Pannell R; Forster A; Rabbitts TH
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):320-4. PubMed ID: 10618416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LIM domain proteins in leukaemia and development.
    Sánchez-García I; Rabbitts TH
    Semin Cancer Biol; 1993 Dec; 4(6):349-58. PubMed ID: 8142620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.
    Yamada Y; Warren AJ; Dobson C; Forster A; Pannell R; Rabbitts TH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3890-5. PubMed ID: 9520463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice.
    Larson RC; Osada H; Larson TA; Lavenir I; Rabbitts TH
    Oncogene; 1995 Sep; 11(5):853-62. PubMed ID: 7545805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development.
    Jurata LW; Kenny DA; Gill GN
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11693-8. PubMed ID: 8876198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
    Okuda T; van Deursen J; Hiebert SW; Grosveld G; Downing JR
    Cell; 1996 Jan; 84(2):321-30. PubMed ID: 8565077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the proto-oncogene rhombotin-2 is identical to the acute phase response protein metallothionein, suggesting multiple functions.
    Neale GA; Mao S; Parham DM; Murti KG; Goorha RM
    Cell Growth Differ; 1995 May; 6(5):587-96. PubMed ID: 7544155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis.
    Rabbitts TH; Axelson H; Forster A; Grutz G; Lavenir I; Larson R; Osada H; Valge-Archer V; Wadman I; Warren A
    Leukemia; 1997 Apr; 11 Suppl 3():271-2. PubMed ID: 9209362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.